PRESENTED BY:
VISHNU.R.NAIR,
4TH YEAR PHARM.D,
NATIONAL COLLEGE OF PHARMACY
GENERAL INTRODUCTION 
HELSINKI DECLARATION 
OTHER NAMES FOR IEC 
RESPONSIBILITIES/ FUNCTIONS OF IEC
COMPOSITION OF IEC 
STEPS INVOLVED IN IEC REVIEW 
BIBLIOGRAPHY/ REFERENCE 
An ETHICS COMMITTEE is defined as :
“A COMMITTEE, formally DESIGNATED, to :
a. REVIEW & APPROVE the initiation of a CLINICAL RESEARCH, involving
HUMAN PARTICIPANTS
b. To PROVIDE CONTINUING REVIEW of the RESEARCH
STUDY”……………………
The ETHICAL & SCIENTIFIC STANDARDS, for carrying out BIOMEDICAL
RESEARCH on human subjects are developed and established, according to:
a. HELSINKI DECLARATION
b. INTERNATIONAL ETHICAL GUIDELINES for BIOMEDICAL RESEARCH
INVOLVING HUMAN SUBJECTS
c. WHO & ICH GUIDELINES for GCP(GOOD CLINICAL PRACTICE)
 The WORLD MEDICAL ASSOCIATION has developed the DECLARATION OF
HELSINKI, as a statement of ETHICAL PRINCIPLES, to provide GUIDANCE to
PHYSICIANS & other PARTICIPANTS in MEDICAL RESEARCH involving
HUMAN SUBJECTS
 PRINCIPLES of HELSINKI DECLARATION include:
1. It is the duty of the physician in medical research, to protect the life, health,
privacy & dignity of the human subject
2. Medical research involving human subjects MUST CONFORM to GENERALLY
ACCEPTED SCIENTIFIC PRINCIPLES
3. Appropriate CAUTION must be EXERCISE in the CONDUCT of the
RESEARCH, which may affect the environment
4. The DESIGN & PERFORMANCE of each EXPERIMENTAL PROCEDURE,
should be clearly FORMULATED in an EXPERIMENTAL PROTOCOL
5. MEDICAL RESEARCH involving human subjects, should be conducted ONLY
BY SCIENTIFICALLY QUALIFIED PERSONS, and under the SUPERVISION of a
CLINICALLY COMPETENT MEDICAL PERSON
6. PHYSICIANS should CEASE any INVESTIGATION, if the RISK are found to
OUTWEIGHT the BENEFITS
7. The SUBJECTS must be VOLUNTEERS and INFORMED PARTICIPANTS in
the RESEARCH PROJECT
8. Every precaution should be taken to:
a. RESPECT SUBJECT PRIVACY
b. RESPECT CONFIDENTIALITY of PATIENT’S INFORMATION
c. MINIMIZE impact of the study on the subject’s PHYSICAL & MENTAL
INTEGRITY, as well as PERSONALITY……………………….
OTHER NAMES INCLUDE:
1. IRB (INSTITUTIONAL REVIEW BOARD)
2. REB(RESEARCH ETHICS BOARD)
3. REC(RESEARCH AND ETHICS COMMITTEE)
4. ERB(ETHICS REVIEW BOARD)……………………..
1. ETHICAL COMMITTEES should establish STANDARD OPERATING
PROCEDURES, that state:
a. FUNCTIONS & DUTIES of EC
b. MEMBERSHIP REQUIREMENTS
c. TERMS & CONDITIONS OF APPOINTMENT
d. INTERNAL PROCEDURES
e. QUORUM REQUIREMENTS
2. To provide COMPETENT REVIEW of all ETHICAL ASPECTS of the PROJECT
3. To UNDERTAKE REVIEW, free from BIAS & INFLUENCE
4. To PROVIDE ADVICE to the RESEARCHERS on all aspects of WELFARE &
SAFETY of RESEARCH PARTICIPANTS
5. To PROTECT DIGNITY, RIGHTS & WELL-BEING of the POTENTIAL
RESEARCH PARTICIPANTS
6. To ENSURE UNIVERSAL ETHICAL VALUES
7. To COMPLY with INTERNATIONAL SCIENTIFIC STANDARDS , in terms of
LOCAL COMMUNITY VALUES and CUSTOMS
8. To assist in the DEVELOPMENT & EDUCATION of RESEARCH
COMMUNITY responsive to local health care requirements……………………….
1. Involves MULTIDISCIPLINARY & MULTISECTORIAL COMPOSITION,
comprising a minimum of 8-12 members
2. MEMBERS include:
a. CHAIR PERSON ( Maintains INDEPENDENCE of the COMMITTEE)
b. MEMBER SECRETARY (Conducts the BUSINESS of the COMMITTEE)
c. 1-2 MEDICAL SCIENTISTS
d. 1-2 CLINICIANS FROM VARIOUS INSTITUTES
e. 1 LEGAL EXPERT/ RETIRED JUDGE
f. 1 SOCIAL SCIENTIST/ REPRESENTATIVE OF NON-GOVERNMENTAL
VOLUNTARY AGENCY
g. ONE PHILOSOPHER/ ETHICIST/ THEOLOGIAN
h. 1 COMMON MAN
STEPS INCLUDE:
FIXING OF IEC DATE  SUBMISSIONS MADE BY
RESEARCHERS  REVIEWERS ARE SELECTED 
PROPOSAL SENT TO THE REVIEWERS FOR REVIEW 
REVIEW CONDUCTED  RESULTS OF REVIEWS ARE
DISCUSSED IN AN IEC MEETING  BASED ON
DISCUSSIONS, DECISION IS MADE 
DOCUMENTATION OF DECISIONS & DISCUSSIONS 
DECISIONS ARE SUBMITTED TO THE RESEARCHERS 
REVISION / RESUBMISSION DONE (BASED ON
SITUATION)  APPROVAL OF THE RESEARCH…..
SUBMISSION OF APPLICATION OF RESEARCH TO IEC:
The following documents should be submitted:
1. TRIAL PROTOCOL(in prescribed format)
2. PATIENT INFORMATION SHEET & INFORMED CONSENT FORM , along
with its TRANSLATIONS
3. INVESTIGATOR’S BROCHURE
4. PRINCIPAL INVESTIGATOR’S CURRENT CURRICULUM VITAE
5. INSURANCE POLICY/COMPENSATION FOR PARTICIPATION
6. INVESTIGATOR’S AGREEMENT with the SPONSOR……………
REVIEW OF PROJECT:
1. SCIENTIFIC EVALUATION should be completed before ethical evaluation
2. Evaluate POSSIBLE RISKS to the subjects, with PROPER JUSTIFICATION
3. Focus on the EXPECTED BENEFITS of the study
4. Check the ADEQUACY of DOCUMENTATION, to ensure PRIVACY,
CONFIDENTIALITY & JUSTICE ISSUES
5. ETHICAL REVIEW should be done through FORMAL MEETINGS
6. DECISIONS are preferably arrived at on a common basis
7. IEC’S MEMBER SECRETARY  Screens the PROPOSALS for their
COMPLETENESS
8. Depending on risk involved, SECRETARY CATEGORIZES PROPOSALS into:
a. EXPEDITED REVIEW
b. FULL REVIEW
c. EXEMPTED FROM REVIEW
a. EXPEDITED REVIEW:
- Refer to “Those SEARCH PROJECTS, with NO MORE THAN MINIMAL RISK
to RESEARCH PARTICIPANTS”
- Examples include:
• Clinical studies of drugs and medical devices
- Research involves already approved drugs, or when an ADVERSE EVENT/
UNEXPECTED ADVERSE REACTION is reported
b. FULL REVIEW:
- Refer to “ALL RESEARCH PROPOSALS, with MORE THAN MINIMAL RISK”
- Example: Projects, involving VULNERABLE POPULATION (children,
psychiatric patients)
- FULL REVIEW is carried out in cases, involving:
• COLLECTION of BLOOD SAMPLES
• COLLECTION of BIOLOGICAL SAMPLES (Sputum, skin, amniotic fluid,
etc)……..
c. EXEMPTED FROM REVIEW:
- Refer to “Those research proposals, with LESS THAN MINIMAL RISK”
- Examples:
• Research on educational practice
• Instructional technics
• Curricula
• Classroom management methods………………………………
TYPES OF REVIEW:
A. PERIODIC REVIEW:
- Ongoing research  reviewed at regular intervals of 6 MONTHS- 1 YEAR
B. CONTINUING REVIEW:
- The IEC has the responsibility to CONTINUE reviewing APPROVED
PROJECTS for CONTINUATION, NEW INFORMATION, ADVERSE EVENT
MONITORING, FOLLOW-UP, etc
C. INTERIM REVIEW:
- INTERIM REVIEW  decides SPECIAL CIRCUMSTANCES for review by SUB-
COMMITTEE
- Involves RE-EXAMINATION of PROPOSAL, already EXAMINED by
IEC……………
METHODOLOGY INVOLVED IN ETHICAL REVIEW:
The methodology for ethical review includes:
1. SCIENTIFIC DESIGN & CONDUCT OF STUDY
2. RECRUITMENT OF RESEARCH PARTICIPANTS
3. CARE & PROTECTION OF RESEARCH PARTICIPANTS
4. PROTECTION OF RESEARCH PARTICIPANT
CONFIDENTIALITY
5. INFORMED CONSENT PROCESS
1. SCIENTIFIC DESIGN & CONDUCT OF STUDY :
Include the following:
a. APPROPRIATENESS of study design
b. STATISTICAL METHODOLOGY, including SAMPLE SIZE CALCULATION
c. RISK vs ANTICIPATED BENEFITS for research participants
d. JUSTIFICATION for CONTROLS used
e. WITHDRAWAL CRITERIA of participants
f. CRITERIA for TRIAL TERMINATION
g. ADEQUACY for MONITORING & AUDITING the CONDUCT of RESEARCH
h. SITE FACILITIES for handling EMERGENCIES
i. REPORTING & PUBLICATION ISSUES
2. RECRUITMENT OF RESEARCH PARTICIPANTS:
- Includes the following:
a. STUDY POPULATION – DEMOGRAPHIC CHARACTERISTICS
b. Means by which participants are CONTACTED and RECRUITED
c. Means by which full information is conveyed to research participants or their
representatives
- CRITERIA for recruitments include:
a. Inclusion criteria
b. Exclusion criteria
3. CARE & PROTECTION OF RESEARCH PARTICIPANTS:
- Include:
a. MEDICAL CARE to be provided to participants during & after research
b. ADEQUACY of MEDICAL SUPERVISION
c. STEPS TAKEN, if participants VOLUNTARILY WITHDRAW from study
d. INFORMED CONSENT
e. INSURANCE & INDEMNITY ARRANGEMENTS
4. PROTECTION OF RESEARCH PARTICIPANT
CONFIDENTIALITY:
Includes:
- DESCRIPTION of persons, who will have access to personal data of research
participants, including MEDICAL RECORDS & BIOLOGICAL SAMPLES
- Measures, taken to ensure the CONFIDENTIALITY & SECURITY of
PERSONAL INFORMATION concerning research participants
5. INFORMED CONSENT PROCESS:
Includes:
a. ADEQUACY, COMPLETENESS UNDERSTANDABILITY of WRITTEN &
ORAL INFORMATION given to participants / their LEGAL
REPRESENTATIVES
b. CLEAR JUSTIFICATION, for intention to include RESEARCH INDIVIDUALS
, who cannot consent
c. ASSURANCE, that participants will receive any new information, that
becomes available
d. CONTACT DETAILS of persons, whom the participants need to contact for any
complaints or queries
DECISION:
Based on reviews and proposals held in IEC MEETINGS, decisions on
research proposals are made, which are classified into:
A. OUTRIGHT APPROVAL:
- Refers to applications, that contain ALL NECESSARY INFORMATION
- Only very minor changes are suggested
B. APPROVAL, WITH MODIFICATIONS:
- Refers to applications, that contain ENOUGH INFORMATION to JUDGE the
STUDY, but CLARIFICATION / CHANGES are needed
C. RESUBMIT, WITH MORE INFORMATION:
- Refers to applications, that do NOT contain enough information to judge the
application appropriately
D. OUTRIGHT DISAPPROVAL:
- Refers to those applications, in which there is ABSOLUTELY NO WAY OF
DOING ETHICAL STUDY…………………………….
1. TIPNIS.H.J; BAJAJ.A; “RESEARCH AND ETHICS
COMMITTEE” ; A TEXTBOOK OF HOSPITAL
PHARMACY, CAREER PUBLICATIONS, PAGE: 80-82
2. http://www.slideshare.net/Dr.Sirisha/IEC
3. JAMES.A; “RESEARCH AND ETHICAL COMMITTEE
OR IRB”
4. YADAV.G; “INSTITUTIONAL ETHICS COMMITTEE &
INFORMED CONSENT”
THANK YOU !!!!!
  

More Related Content

PPTX
Inform consent , M k sharma
PPTX
Institutional review board by akshdeep sharma
PPTX
Clinical trial monitoring
PPTX
Designing of clinical study protocol rumana hameed
PPTX
Institutional Review Board
PPT
Good Clinical Practice Guidelines (ICH GCP E6).ppt
PPTX
Protocol development
PPTX
CLINICAL TRIALS REGISTRY-INDIA.pptx
Inform consent , M k sharma
Institutional review board by akshdeep sharma
Clinical trial monitoring
Designing of clinical study protocol rumana hameed
Institutional Review Board
Good Clinical Practice Guidelines (ICH GCP E6).ppt
Protocol development
CLINICAL TRIALS REGISTRY-INDIA.pptx

What's hot (20)

PDF
Preparation of Clinical Trial Protocol of India.
PPTX
Clinical trail protocol and development
PPTX
Case report form and application
DOCX
Designing of clinical study documentation -protocol and crf
PPTX
Informed consent in Clinical Trials
PPTX
Institutional review board/Independent ethics Committee
PPTX
Clinical Data Management
PPTX
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
PPTX
Investigator Role and Responsibilities
PPTX
Clinical Trial Safety Monitoring.pptx
PPTX
Roles and Responsibilities of sponsor, CRO, and investigator
PPTX
Clinical trial protocol, ammendments, Protocol deviations and violations
PPTX
Investigator's Brochure
PPTX
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
PPTX
Clinical Trial Protocol
PDF
Documentation clinical trial
PPT
Clinical Trial Registration
PDF
Cinical trial protocol writing
PPTX
institutional review board and independent ethics committee
PPTX
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
Preparation of Clinical Trial Protocol of India.
Clinical trail protocol and development
Case report form and application
Designing of clinical study documentation -protocol and crf
Informed consent in Clinical Trials
Institutional review board/Independent ethics Committee
Clinical Data Management
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...
Investigator Role and Responsibilities
Clinical Trial Safety Monitoring.pptx
Roles and Responsibilities of sponsor, CRO, and investigator
Clinical trial protocol, ammendments, Protocol deviations and violations
Investigator's Brochure
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
Clinical Trial Protocol
Documentation clinical trial
Clinical Trial Registration
Cinical trial protocol writing
institutional review board and independent ethics committee
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
Ad

Similar to Institutional ethics committee(IEC): A brief insight, by Rxvichu!! (20)

PPTX
ICMR guidelines for IEC - an overview
PPTX
Indian gcp guidelines[647]
PPTX
Codes of ethics for biologist By Anita bibi
PPTX
Indian gcp ppt cr by ann
PPTX
Good Clinical Practice Guidelines ppt.pptx
DOCX
Ethical guidelines for biomedical research in human participants
DOCX
Ethical guidelines for biomedical research in human participants
PPTX
institutional ethics committee
PPTX
Institutional ethics committee : Roles and Responsibilities
PDF
Role of IRB and IEC in Safeguarding the Subjects in Clinical Trials
PPTX
Institutional ethics committee & informed consent
PDF
Unit-1, Clinical Research and Pharmacovigilance (MPL 204T) .pdf
PPTX
SCHS Topic7 research ethics
PPTX
Addressing ethics in clinical research
PPTX
ICH GCP by Yogesh Yadav.pptx
PPTX
Icmr ethical guidelines for biomedical research on human subject
PDF
Assignment on Regulatory Prespectives of Clinical Trials
PPTX
Nr 1 in 3
PPTX
PHASE 1 PROTOCOL DESIGN for clinical trials.pptx
ICMR guidelines for IEC - an overview
Indian gcp guidelines[647]
Codes of ethics for biologist By Anita bibi
Indian gcp ppt cr by ann
Good Clinical Practice Guidelines ppt.pptx
Ethical guidelines for biomedical research in human participants
Ethical guidelines for biomedical research in human participants
institutional ethics committee
Institutional ethics committee : Roles and Responsibilities
Role of IRB and IEC in Safeguarding the Subjects in Clinical Trials
Institutional ethics committee & informed consent
Unit-1, Clinical Research and Pharmacovigilance (MPL 204T) .pdf
SCHS Topic7 research ethics
Addressing ethics in clinical research
ICH GCP by Yogesh Yadav.pptx
Icmr ethical guidelines for biomedical research on human subject
Assignment on Regulatory Prespectives of Clinical Trials
Nr 1 in 3
PHASE 1 PROTOCOL DESIGN for clinical trials.pptx
Ad

More from RxVichuZ (20)

PPTX
Parkinson Disease Pathophysiology #Dr. Vishnu!
PPT
HIV Pathophysiology, by Dr. Vishnu
PPT
General principles involved in management of poisoning (Part 1)
PPTX
Buprenorphine drug profile by Dr. Vishnu!
PDF
5-Alpha reductase inhibitors drug profile
PDF
Rational use of antibiotics by RxVichuZ!
PDF
Co-trimoxazole drug profile by RxVichuZ!
PDF
Amoxicillin drug profile: By RxVichuZ! :)
PPTX
Food drug interactions with penicillins: by RxVichuZ!
PPTX
Snake bite poisoning and its treatment by RxVichuZ!
PPTX
Case study on Heart Failure by RxVichuZ!
PPTX
Directly acting antivirals and Visceral Leishmaniasis: A case report
PPTX
Drug mnemonics; by RxVichuZ! ;)
PPTX
Acute coronary syndrome management by RxVichuZ! ;)
PPTX
RNTCP guidelines for tuberculosis management: Extended version
PPTX
Journal club presentation: by RxVichuZ!! ;)
PPTX
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPTX
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
PPTX
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
PPTX
Sulfonylureas for Diabetes: A deep insight
Parkinson Disease Pathophysiology #Dr. Vishnu!
HIV Pathophysiology, by Dr. Vishnu
General principles involved in management of poisoning (Part 1)
Buprenorphine drug profile by Dr. Vishnu!
5-Alpha reductase inhibitors drug profile
Rational use of antibiotics by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!
Amoxicillin drug profile: By RxVichuZ! :)
Food drug interactions with penicillins: by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!
Case study on Heart Failure by RxVichuZ!
Directly acting antivirals and Visceral Leishmaniasis: A case report
Drug mnemonics; by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)
RNTCP guidelines for tuberculosis management: Extended version
Journal club presentation: by RxVichuZ!! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Sulfonylureas for Diabetes: A deep insight

Recently uploaded (20)

PPTX
approach to chest pain dr. Omar shahid ppt
PDF
New-Child for VP Shunt Placement – Anaesthetic Management - Copy (1).pdf
PPTX
Vesico ureteric reflux.. Introduction and clinical management
PPTX
thio and propofol mechanism and uses.pptx
PDF
Geriatrics Chapter 1 powerpoint for PA-S
PPTX
presentation on dengue and its management
PPTX
Method of organizing health promotion and education and counselling activitie...
PDF
Gynecologic Malignancies.Dawit.pdf............
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PPTX
BIOCOMPATIBILITY & BIOLOGICAL CONSIDERATION OF DENTAL MATERIALS.pptx
PPTX
HOP RELATED TO NURSING EDUCATION FOR BSC
PPT
fiscal planning in nursing and administration
PPTX
INDA & ANDA presentation explains about the
PPTX
abgs and brain death dr js chinganga.pptx
PDF
Impact of Technology on Patient Autonomy (www.kiu.ac.ug)
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PPTX
Hypertensive disorders in pregnancy.pptx
PDF
Nursing manual for conscious sedation.pdf
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
approach to chest pain dr. Omar shahid ppt
New-Child for VP Shunt Placement – Anaesthetic Management - Copy (1).pdf
Vesico ureteric reflux.. Introduction and clinical management
thio and propofol mechanism and uses.pptx
Geriatrics Chapter 1 powerpoint for PA-S
presentation on dengue and its management
Method of organizing health promotion and education and counselling activitie...
Gynecologic Malignancies.Dawit.pdf............
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
BIOCOMPATIBILITY & BIOLOGICAL CONSIDERATION OF DENTAL MATERIALS.pptx
HOP RELATED TO NURSING EDUCATION FOR BSC
fiscal planning in nursing and administration
INDA & ANDA presentation explains about the
abgs and brain death dr js chinganga.pptx
Impact of Technology on Patient Autonomy (www.kiu.ac.ug)
Approach to chest pain, SOB, palpitation and prolonged fever
Hypertensive disorders in pregnancy.pptx
Nursing manual for conscious sedation.pdf
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv

Institutional ethics committee(IEC): A brief insight, by Rxvichu!!

  • 1. PRESENTED BY: VISHNU.R.NAIR, 4TH YEAR PHARM.D, NATIONAL COLLEGE OF PHARMACY
  • 2. GENERAL INTRODUCTION  HELSINKI DECLARATION  OTHER NAMES FOR IEC  RESPONSIBILITIES/ FUNCTIONS OF IEC COMPOSITION OF IEC  STEPS INVOLVED IN IEC REVIEW  BIBLIOGRAPHY/ REFERENCE 
  • 3. An ETHICS COMMITTEE is defined as : “A COMMITTEE, formally DESIGNATED, to : a. REVIEW & APPROVE the initiation of a CLINICAL RESEARCH, involving HUMAN PARTICIPANTS b. To PROVIDE CONTINUING REVIEW of the RESEARCH STUDY”…………………… The ETHICAL & SCIENTIFIC STANDARDS, for carrying out BIOMEDICAL RESEARCH on human subjects are developed and established, according to: a. HELSINKI DECLARATION b. INTERNATIONAL ETHICAL GUIDELINES for BIOMEDICAL RESEARCH INVOLVING HUMAN SUBJECTS c. WHO & ICH GUIDELINES for GCP(GOOD CLINICAL PRACTICE)
  • 4.  The WORLD MEDICAL ASSOCIATION has developed the DECLARATION OF HELSINKI, as a statement of ETHICAL PRINCIPLES, to provide GUIDANCE to PHYSICIANS & other PARTICIPANTS in MEDICAL RESEARCH involving HUMAN SUBJECTS  PRINCIPLES of HELSINKI DECLARATION include: 1. It is the duty of the physician in medical research, to protect the life, health, privacy & dignity of the human subject 2. Medical research involving human subjects MUST CONFORM to GENERALLY ACCEPTED SCIENTIFIC PRINCIPLES 3. Appropriate CAUTION must be EXERCISE in the CONDUCT of the RESEARCH, which may affect the environment 4. The DESIGN & PERFORMANCE of each EXPERIMENTAL PROCEDURE, should be clearly FORMULATED in an EXPERIMENTAL PROTOCOL
  • 5. 5. MEDICAL RESEARCH involving human subjects, should be conducted ONLY BY SCIENTIFICALLY QUALIFIED PERSONS, and under the SUPERVISION of a CLINICALLY COMPETENT MEDICAL PERSON 6. PHYSICIANS should CEASE any INVESTIGATION, if the RISK are found to OUTWEIGHT the BENEFITS 7. The SUBJECTS must be VOLUNTEERS and INFORMED PARTICIPANTS in the RESEARCH PROJECT 8. Every precaution should be taken to: a. RESPECT SUBJECT PRIVACY b. RESPECT CONFIDENTIALITY of PATIENT’S INFORMATION c. MINIMIZE impact of the study on the subject’s PHYSICAL & MENTAL INTEGRITY, as well as PERSONALITY……………………….
  • 6. OTHER NAMES INCLUDE: 1. IRB (INSTITUTIONAL REVIEW BOARD) 2. REB(RESEARCH ETHICS BOARD) 3. REC(RESEARCH AND ETHICS COMMITTEE) 4. ERB(ETHICS REVIEW BOARD)……………………..
  • 7. 1. ETHICAL COMMITTEES should establish STANDARD OPERATING PROCEDURES, that state: a. FUNCTIONS & DUTIES of EC b. MEMBERSHIP REQUIREMENTS c. TERMS & CONDITIONS OF APPOINTMENT d. INTERNAL PROCEDURES e. QUORUM REQUIREMENTS 2. To provide COMPETENT REVIEW of all ETHICAL ASPECTS of the PROJECT 3. To UNDERTAKE REVIEW, free from BIAS & INFLUENCE 4. To PROVIDE ADVICE to the RESEARCHERS on all aspects of WELFARE & SAFETY of RESEARCH PARTICIPANTS
  • 8. 5. To PROTECT DIGNITY, RIGHTS & WELL-BEING of the POTENTIAL RESEARCH PARTICIPANTS 6. To ENSURE UNIVERSAL ETHICAL VALUES 7. To COMPLY with INTERNATIONAL SCIENTIFIC STANDARDS , in terms of LOCAL COMMUNITY VALUES and CUSTOMS 8. To assist in the DEVELOPMENT & EDUCATION of RESEARCH COMMUNITY responsive to local health care requirements……………………….
  • 9. 1. Involves MULTIDISCIPLINARY & MULTISECTORIAL COMPOSITION, comprising a minimum of 8-12 members 2. MEMBERS include: a. CHAIR PERSON ( Maintains INDEPENDENCE of the COMMITTEE) b. MEMBER SECRETARY (Conducts the BUSINESS of the COMMITTEE) c. 1-2 MEDICAL SCIENTISTS d. 1-2 CLINICIANS FROM VARIOUS INSTITUTES e. 1 LEGAL EXPERT/ RETIRED JUDGE f. 1 SOCIAL SCIENTIST/ REPRESENTATIVE OF NON-GOVERNMENTAL VOLUNTARY AGENCY g. ONE PHILOSOPHER/ ETHICIST/ THEOLOGIAN h. 1 COMMON MAN
  • 10. STEPS INCLUDE: FIXING OF IEC DATE  SUBMISSIONS MADE BY RESEARCHERS  REVIEWERS ARE SELECTED  PROPOSAL SENT TO THE REVIEWERS FOR REVIEW  REVIEW CONDUCTED  RESULTS OF REVIEWS ARE DISCUSSED IN AN IEC MEETING  BASED ON DISCUSSIONS, DECISION IS MADE  DOCUMENTATION OF DECISIONS & DISCUSSIONS  DECISIONS ARE SUBMITTED TO THE RESEARCHERS  REVISION / RESUBMISSION DONE (BASED ON SITUATION)  APPROVAL OF THE RESEARCH…..
  • 11. SUBMISSION OF APPLICATION OF RESEARCH TO IEC: The following documents should be submitted: 1. TRIAL PROTOCOL(in prescribed format) 2. PATIENT INFORMATION SHEET & INFORMED CONSENT FORM , along with its TRANSLATIONS 3. INVESTIGATOR’S BROCHURE 4. PRINCIPAL INVESTIGATOR’S CURRENT CURRICULUM VITAE 5. INSURANCE POLICY/COMPENSATION FOR PARTICIPATION 6. INVESTIGATOR’S AGREEMENT with the SPONSOR……………
  • 12. REVIEW OF PROJECT: 1. SCIENTIFIC EVALUATION should be completed before ethical evaluation 2. Evaluate POSSIBLE RISKS to the subjects, with PROPER JUSTIFICATION 3. Focus on the EXPECTED BENEFITS of the study 4. Check the ADEQUACY of DOCUMENTATION, to ensure PRIVACY, CONFIDENTIALITY & JUSTICE ISSUES 5. ETHICAL REVIEW should be done through FORMAL MEETINGS 6. DECISIONS are preferably arrived at on a common basis 7. IEC’S MEMBER SECRETARY  Screens the PROPOSALS for their COMPLETENESS 8. Depending on risk involved, SECRETARY CATEGORIZES PROPOSALS into: a. EXPEDITED REVIEW b. FULL REVIEW c. EXEMPTED FROM REVIEW
  • 13. a. EXPEDITED REVIEW: - Refer to “Those SEARCH PROJECTS, with NO MORE THAN MINIMAL RISK to RESEARCH PARTICIPANTS” - Examples include: • Clinical studies of drugs and medical devices - Research involves already approved drugs, or when an ADVERSE EVENT/ UNEXPECTED ADVERSE REACTION is reported b. FULL REVIEW: - Refer to “ALL RESEARCH PROPOSALS, with MORE THAN MINIMAL RISK” - Example: Projects, involving VULNERABLE POPULATION (children, psychiatric patients) - FULL REVIEW is carried out in cases, involving: • COLLECTION of BLOOD SAMPLES • COLLECTION of BIOLOGICAL SAMPLES (Sputum, skin, amniotic fluid, etc)……..
  • 14. c. EXEMPTED FROM REVIEW: - Refer to “Those research proposals, with LESS THAN MINIMAL RISK” - Examples: • Research on educational practice • Instructional technics • Curricula • Classroom management methods………………………………
  • 15. TYPES OF REVIEW: A. PERIODIC REVIEW: - Ongoing research  reviewed at regular intervals of 6 MONTHS- 1 YEAR B. CONTINUING REVIEW: - The IEC has the responsibility to CONTINUE reviewing APPROVED PROJECTS for CONTINUATION, NEW INFORMATION, ADVERSE EVENT MONITORING, FOLLOW-UP, etc C. INTERIM REVIEW: - INTERIM REVIEW  decides SPECIAL CIRCUMSTANCES for review by SUB- COMMITTEE - Involves RE-EXAMINATION of PROPOSAL, already EXAMINED by IEC……………
  • 16. METHODOLOGY INVOLVED IN ETHICAL REVIEW: The methodology for ethical review includes: 1. SCIENTIFIC DESIGN & CONDUCT OF STUDY 2. RECRUITMENT OF RESEARCH PARTICIPANTS 3. CARE & PROTECTION OF RESEARCH PARTICIPANTS 4. PROTECTION OF RESEARCH PARTICIPANT CONFIDENTIALITY 5. INFORMED CONSENT PROCESS
  • 17. 1. SCIENTIFIC DESIGN & CONDUCT OF STUDY : Include the following: a. APPROPRIATENESS of study design b. STATISTICAL METHODOLOGY, including SAMPLE SIZE CALCULATION c. RISK vs ANTICIPATED BENEFITS for research participants d. JUSTIFICATION for CONTROLS used e. WITHDRAWAL CRITERIA of participants f. CRITERIA for TRIAL TERMINATION g. ADEQUACY for MONITORING & AUDITING the CONDUCT of RESEARCH h. SITE FACILITIES for handling EMERGENCIES i. REPORTING & PUBLICATION ISSUES
  • 18. 2. RECRUITMENT OF RESEARCH PARTICIPANTS: - Includes the following: a. STUDY POPULATION – DEMOGRAPHIC CHARACTERISTICS b. Means by which participants are CONTACTED and RECRUITED c. Means by which full information is conveyed to research participants or their representatives - CRITERIA for recruitments include: a. Inclusion criteria b. Exclusion criteria
  • 19. 3. CARE & PROTECTION OF RESEARCH PARTICIPANTS: - Include: a. MEDICAL CARE to be provided to participants during & after research b. ADEQUACY of MEDICAL SUPERVISION c. STEPS TAKEN, if participants VOLUNTARILY WITHDRAW from study d. INFORMED CONSENT e. INSURANCE & INDEMNITY ARRANGEMENTS
  • 20. 4. PROTECTION OF RESEARCH PARTICIPANT CONFIDENTIALITY: Includes: - DESCRIPTION of persons, who will have access to personal data of research participants, including MEDICAL RECORDS & BIOLOGICAL SAMPLES - Measures, taken to ensure the CONFIDENTIALITY & SECURITY of PERSONAL INFORMATION concerning research participants
  • 21. 5. INFORMED CONSENT PROCESS: Includes: a. ADEQUACY, COMPLETENESS UNDERSTANDABILITY of WRITTEN & ORAL INFORMATION given to participants / their LEGAL REPRESENTATIVES b. CLEAR JUSTIFICATION, for intention to include RESEARCH INDIVIDUALS , who cannot consent c. ASSURANCE, that participants will receive any new information, that becomes available d. CONTACT DETAILS of persons, whom the participants need to contact for any complaints or queries
  • 22. DECISION: Based on reviews and proposals held in IEC MEETINGS, decisions on research proposals are made, which are classified into: A. OUTRIGHT APPROVAL: - Refers to applications, that contain ALL NECESSARY INFORMATION - Only very minor changes are suggested B. APPROVAL, WITH MODIFICATIONS: - Refers to applications, that contain ENOUGH INFORMATION to JUDGE the STUDY, but CLARIFICATION / CHANGES are needed C. RESUBMIT, WITH MORE INFORMATION: - Refers to applications, that do NOT contain enough information to judge the application appropriately
  • 23. D. OUTRIGHT DISAPPROVAL: - Refers to those applications, in which there is ABSOLUTELY NO WAY OF DOING ETHICAL STUDY…………………………….
  • 24. 1. TIPNIS.H.J; BAJAJ.A; “RESEARCH AND ETHICS COMMITTEE” ; A TEXTBOOK OF HOSPITAL PHARMACY, CAREER PUBLICATIONS, PAGE: 80-82 2. http://www.slideshare.net/Dr.Sirisha/IEC 3. JAMES.A; “RESEARCH AND ETHICAL COMMITTEE OR IRB” 4. YADAV.G; “INSTITUTIONAL ETHICS COMMITTEE & INFORMED CONSENT”